全球免疫球蛋白市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計免疫球蛋白市場將從 2025 年的 239.4 億美元成長到 2034 年的 417 億美元，2026 年至 2034 年的複合年成長率為 6.36%。

受免疫不全症和自體免疫疾病日益普遍的推動，全球免疫球蛋白市場正經歷強勁成長。免疫球蛋白是重要的血漿衍生療法，用於增強免疫力並治療多種神經系統和血液系統疾病。診斷率的提高和人們對罕見疾病認知的增強也顯著促進了全球需求的成長。

血漿分餾技術的進步和捐贈者網路的擴張是推動市場成長要素。新適應症的核准和健保報銷政策的改善也進一步促進了市場成長。此外，醫療保健支出的增加和生物製藥生產投資的加大也為免疫球蛋白產品的全球大規模生產和分銷提供了支持。

隨著研究不斷探索更多治療應用，未來前景依然強勁。新興市場可望憑藉醫療基礎設施和診斷能力的提升，帶來巨大的發展機會。皮下注射免疫球蛋白製劑和居家靜脈輸液療法等創新技術將提升病患就醫便利性，並推動市場長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球免疫球蛋白市場：依應用分類

• 市場分析、洞察與預測
• 神經病學
• 免疫學
• 血液學
• 其他

第5章：全球免疫球蛋白市場：依給藥途徑分類

• 市場分析、洞察與預測
• 靜脈注射
• 皮下注射
• 肌肉內注射

第6章 全球免疫球蛋白市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診所
• 居家照護

第7章 全球免疫球蛋白市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Shire
  • CSL Behring
  • Kedrion Biopharma Inc
  • Grifols SA
  • Octapharma
  • China Biologic Products Holdings Inc
  • Biotest AG
  • Sanquin
  • LFB SA

The Immunoglobulins Market size is expected to reach USD 41.70 Billion in 2034 from USD 23.94 Billion (2025) growing at a CAGR of 6.36% during 2026-2034.

The Global Immunoglobulins Market is experiencing strong growth driven by increasing prevalence of immune deficiency disorders and autoimmune diseases. Immunoglobulins are essential plasma-derived therapies used to boost immunity and treat various neurological and hematological conditions. Growing diagnosis rates and improved awareness of rare diseases are significantly contributing to rising demand worldwide.

Key growth drivers include advancements in plasma fractionation technologies and expanding donor networks. Increasing approvals for new therapeutic indications and improved reimbursement policies are further strengthening market expansion. Additionally, rising healthcare spending and growing investments in biologics manufacturing are supporting large-scale production and distribution of immunoglobulin products globally.

Future prospects appear robust as research continues to explore additional therapeutic applications. Emerging markets are expected to offer substantial opportunities due to improving healthcare infrastructure and diagnostic capabilities. Innovations in subcutaneous immunoglobulin formulations and home-based infusion therapies will likely enhance patient convenience and drive long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Neurology
• Immunology
• Hematology
• Others

By Route of Administration

• Intravenous
• Subcutaneous
• Intramuscular

By End-user

• Hospitals
• Clinics
• Homecare

COMPANIES PROFILED

• Shire, CSL Behring, Kedrion Biopharma Inc, Grifols SA, Octapharma, China Biologic Products Holdings Inc, Biotest AG, Sanquin, LFB SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMMUNOGLOBULINS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMMUNOGLOBULINS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Intravenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Subcutaneous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Intramuscular Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMMUNOGLOBULINS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMMUNOGLOBULINS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Route Of Administration
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Route Of Administration
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Route Of Administration
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Route Of Administration
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Route Of Administration
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IMMUNOGLOBULINS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Shire
  • 9.2.2 CSL Behring
  • 9.2.3 Kedrion Biopharma Inc
  • 9.2.4 Grifols S.A
  • 9.2.5 Octapharma
  • 9.2.6 China Biologic Products Holdings Inc
  • 9.2.7 Biotest AG
  • 9.2.8 Sanquin
  • 9.2.9 LFB SA